Fermín CCA, López KS, Paredes SJG, Ruvalcaba AJ, Arana VMA, Arcos ZM, Nellen HH, Halabe CJ

Idioma: Español
Referencias bibliográficas: 27
Paginas: 503-511
Archivo PDF: 221.43 Kb.

RESUMEN

La fibrosis hepática ocurre en respuesta a diversos tipos de agresión hepática. Las causas más comunes son: hepatitis B y C y consumo de alcohol, otras causas incluyen: alteraciones inmunológicas, anormalidades genéticas, esteatohepatitis no alcohólica, asociada con diabetes mellitus u otros problemas metabólicos y, por último, las afecciones que provocan colestasis crónica. La cirrosis biliar secundaria ocurre después de un largo periodo de obstrucción de las vías biliares, ya sea por cálculos o estenosis biliares. Se comunica el caso de un paciente de 64 años de edad, con datos de fibrosis hepática y antecedentes de colecistectomía. También se hace una revisión bibliográfica del abordaje diagnóstico y terapéutico de la colestasis y de la cirrosis biliar.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Iredale J. Cirrosis: new research provides a basis for rational and targeted treatments. BMJ 2003;327:143-7.

2. Dufor J-F, DeLellis R, Kaplan M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-5.

3. Kuo-Shyang J, Shou-Chuan S, Hsein-Jar C, Bee-Fong C. Secondary biliary cirrhosis: a limiting factor in the treatment of hepatolitiasis. Arch Surg 1989;124:1301-5.

4. Duffy J, Hines O, Liu J, et al. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. J Gastroenterol 2003;138:941-50.

5. Laso J. Diagnóstico diferencial en medicina interna. 1ª ed. New York: Harcourt-Brace, 1998.

6. Moraca R, Lee T, Ryan J, Traverso W. Long-term biliary function after reconstruction of mayor bile duct injures with hepaticoduodenostomy or hepaticojejunostomy. Arch Surg 2002;137:889-94.

7. Sabiston DC Jr. Textbook of surgery: the biological basis of modern surgical practice. 15th ed. Philadelphia: WB Saunders, 1997.

8. Jeng K-S, Kuo-Shyang J, Ohta I, Fi-Sh Y. Reappraisal of the systematic management of complicated hepatolitiasis with bilateral intrahepatic biliary structures. Arch Surg 1996;131:141-7.

9. Yi-Yin J, Miin-Fu C, Chia-Siu W, et al. Surgical treatment of hepatolithiasis: long-term results. Surgery 1996;120:509-14.

10. Feldman M, Scharschmidt Sleisenger M, et al. Enfermedades gastrointestinales y hepáticas. 6ª ed. Buenos Aires: Panamericana, 2000.

11. Kusano T, Isa T, Ohtsubo M, et al. Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation. J Clin Gastroenterol 2001;33:114-7.

12. Pastor A, Collado PS, González Gallego J. Factors influencing the inhibition of biliary glutathione efflux induced by biliary obstruction. Life Sci 2000;68:69-79.

13. Krähenbühl S, Krähenbühl-Glauser S, Stucki J, Gehr P, Reichen J. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impared mitocondrial metabolism and increased mitochondrial content per hepatocyte. Hepatology 1992;15:1167-72.

14. Gross J, Reichen J, Zeltner T, Zimmermann A. The evolution of changes in quantitative liver function test in rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocytes mass. Hepatology 1987;7(3):457-63.

15. Krähenbühl S, Brass E. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrosis. Hepatology 1991;14:927-34.

16. Krähenbühl S, Stucki J, Reichen J. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis. Hepatology 1992;15:1160-6.

17. Yang W, Benjamín I, Moore K, Portmann B, Alexander B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat. Eur J Pharmacol 2003;461:41-48.

18. Friedman S. Molecular regulation of hepatic fibrosis: an integrated cellular response to tissue injury. J Biol Chem 2000;275(4):2247-50.

19. Iredale J, Benyon R, Pickering J. Mechanism of spontaneous resolution of rat liver fibrosis. J Clin Invest 1998;102:538-49.

20. Corbin I, Buist R, Peeling J, et al. Hepatic 31PMRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 2003;52:1046-53.

21. Krähenbühl L, Shäfer M, Krähenbühl S. Reversibility of hepatic mitocondrial damage in rats with long-term cholestasis. J Hepatol 1998;28:1000-7.

22. Krähenbühl L, Hagenbuch B, Berardi S, Shäfer M, Krähenbühl S. Rapid normalization of hepatic glycogen metabolism in rats with long-term bile duct ligation after biliodigestive anastomosis. J Hepatol 1999;31:656-63.

23. Bonis P, Friedman S, Kaplan M. Is liver fibrosis reversible? N Engl J Med 2001;334:452-4.

24. Hammel P, Couvelard A, O’Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001;344:418-23.

25. Meretto P, Angelucci E, Lucarelli G. Reversibility of cirrhosis in patients cured of talasemia by bone marrow transplantation. Ann Intern Med 2002;136:667-72.

26. Dufor J-F, DeLellis R, Kaplan M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-5.

27. Natarajan S, Theise N, Thung S, et al. Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol 1997;21(3):312-8.